However, IGFBP3 level correlated with disease severity score, relapsing-remitting disease pattern and treatment strategy, indicating the involvement of IGFBP3 in the pathogenesis of MS (67, 69, 70). Here, IGFBP3 is linked to myeloid sarcoma.